BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU) Stock Fundamental Analysis

NASDAQ:BTSGU • US10950A2050

135.36 USD
-0.05 (-0.04%)
Last: Feb 20, 2026, 08:19 PM
Fundamental Rating

4

BTSGU gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. BTSGU has only an average score on both its financial health and profitability. BTSGU is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • BTSGU had positive earnings in the past year.
  • BTSGU had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: BTSGU reported negative net income in multiple years.
  • BTSGU had a positive operating cash flow in 4 of the past 5 years.
BTSGU Yearly Net Income VS EBIT VS OCF VS FCFBTSGU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • BTSGU has a Return On Assets (2.14%) which is comparable to the rest of the industry.
  • With a decent Return On Equity value of 7.13%, BTSGU is doing good in the industry, outperforming 62.75% of the companies in the same industry.
  • With a Return On Invested Capital value of 4.68%, BTSGU perfoms like the industry average, outperforming 52.94% of the companies in the same industry.
  • BTSGU had an Average Return On Invested Capital over the past 3 years of 3.45%. This is significantly below the industry average of 9.00%.
  • The last Return On Invested Capital (4.68%) for BTSGU is above the 3 year average (3.45%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.14%
ROE 7.13%
ROIC 4.68%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
BTSGU Yearly ROA, ROE, ROICBTSGU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

  • BTSGU has a Profit Margin (1.04%) which is comparable to the rest of the industry.
  • With a Operating Margin value of 2.15%, BTSGU perfoms like the industry average, outperforming 49.02% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BTSGU has grown nicely.
  • BTSGU has a worse Gross Margin (12.30%) than 70.59% of its industry peers.
  • BTSGU's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.15%
PM (TTM) 1.04%
GM 12.3%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
BTSGU Yearly Profit, Operating, Gross MarginsBTSGU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BTSGU is destroying value.
  • BTSGU has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, BTSGU has more shares outstanding
  • Compared to 1 year ago, BTSGU has an improved debt to assets ratio.
BTSGU Yearly Shares OutstandingBTSGU Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
BTSGU Yearly Total Debt VS Total AssetsBTSGU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • BTSGU has an Altman-Z score of 5.88. This indicates that BTSGU is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of BTSGU (5.88) is better than 89.22% of its industry peers.
  • BTSGU has a debt to FCF ratio of 9.17. This is a negative value and a sign of low solvency as BTSGU would need 9.17 years to pay back of all of its debts.
  • The Debt to FCF ratio of BTSGU (9.17) is comparable to the rest of the industry.
  • BTSGU has a Debt/Equity ratio of 1.36. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.36, BTSGU is doing worse than 67.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF 9.17
Altman-Z 5.88
ROIC/WACC0.55
WACC8.51%
BTSGU Yearly LT Debt VS Equity VS FCFBTSGU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • BTSGU has a Current Ratio of 1.79. This is a normal value and indicates that BTSGU is financially healthy and should not expect problems in meeting its short term obligations.
  • BTSGU has a Current ratio of 1.79. This is in the better half of the industry: BTSGU outperforms 70.59% of its industry peers.
  • BTSGU has a Quick Ratio of 1.38. This is a normal value and indicates that BTSGU is financially healthy and should not expect problems in meeting its short term obligations.
  • BTSGU's Quick ratio of 1.38 is in line compared to the rest of the industry. BTSGU outperforms 55.88% of its industry peers.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 1.38
BTSGU Yearly Current Assets VS Current LiabilitesBTSGU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 117.02% over the past year.
  • Looking at the last year, BTSGU shows a quite strong growth in Revenue. The Revenue has grown by 17.23% in the last year.
  • The Revenue has been growing by 20.01% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)117.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%254.55%
Revenue 1Y (TTM)17.23%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%14.7%

3.2 Future

  • The Earnings Per Share is expected to grow by 42.20% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, BTSGU will show a quite strong growth in Revenue. The Revenue will grow by 15.42% on average per year.
EPS Next Y97.42%
EPS Next 2Y57.83%
EPS Next 3Y45.31%
EPS Next 5Y42.2%
Revenue Next Year13.42%
Revenue Next 2Y14.12%
Revenue Next 3Y13.85%
Revenue Next 5Y15.42%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BTSGU Yearly Revenue VS EstimatesBTSGU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
BTSGU Yearly EPS VS EstimatesBTSGU Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 132.71, the valuation of BTSGU can be described as expensive.
  • BTSGU's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 26.99. BTSGU is valued rather expensively when compared to this.
  • BTSGU is valuated quite expensively with a Price/Forward Earnings ratio of 98.80.
  • The rest of the industry has a similar Price/Forward Earnings ratio as BTSGU.
  • BTSGU's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 132.71
Fwd PE 98.8
BTSGU Price Earnings VS Forward Price EarningsBTSGU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • BTSGU's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. BTSGU is more expensive than 62.75% of the companies in the same industry.
  • BTSGU's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 88.42
EV/EBITDA 60.13
BTSGU Per share dataBTSGU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • BTSGU's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as BTSGU's earnings are expected to grow with 45.31% in the coming years.
PEG (NY)1.36
PEG (5Y)N/A
EPS Next 2Y57.83%
EPS Next 3Y45.31%

3

5. Dividend

5.1 Amount

  • BTSGU has a Yearly Dividend Yield of 2.67%.
  • Compared to an average industry Dividend Yield of 0.49, BTSGU pays a better dividend. On top of this BTSGU pays more dividend than 95.10% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, BTSGU pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.67%

5.2 History

  • BTSGU has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BTSGU Yearly Dividends per shareBTSGU Yearly Dividends per shareYearly Dividends per share 2024 2025 2026 1 2 3

5.3 Sustainability

DPN/A
EPS Next 2Y57.83%
EPS Next 3Y45.31%
BTSGU Yearly Income VS Free CF VS DividendBTSGU Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27

NASDAQ:BTSGU (2/20/2026, 8:19:58 PM)

135.36

-0.05 (-0.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-20
Earnings (Next)02-27
Inst Owners73.18%
Inst Owner ChangeN/A
Ins Owners2.49%
Ins Owner ChangeN/A
Market Cap24.41B
Revenue(TTM)12.41B
Net Income(TTM)129.59M
Analysts86.36
Price Target148.6 (9.78%)
Short Float %0.03%
Short Ratio1.64
Dividend
Industry RankSector Rank
Dividend Yield 2.67%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date01-15
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.94%
Min EPS beat(2)26.26%
Max EPS beat(2)41.61%
EPS beat(4)3
Avg EPS beat(4)40.55%
Min EPS beat(4)-2.7%
Max EPS beat(4)97.01%
EPS beat(8)5
Avg EPS beat(8)26.15%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.23%
Min Revenue beat(2)3.22%
Max Revenue beat(2)3.24%
Revenue beat(4)3
Avg Revenue beat(4)2.17%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)3.24%
Revenue beat(8)6
Avg Revenue beat(8)2.96%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.48%
PT rev (3m)32.19%
EPS NQ rev (1m)0.44%
EPS NQ rev (3m)9.38%
EPS NY rev (1m)0%
EPS NY rev (3m)6.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.76%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.44%
Valuation
Industry RankSector Rank
PE 132.71
Fwd PE 98.8
P/S 1.97
P/FCF 88.42
P/OCF 69.9
P/B 13.42
P/tB N/A
EV/EBITDA 60.13
EPS(TTM)1.02
EY0.75%
EPS(NY)1.37
Fwd EY1.01%
FCF(TTM)1.53
FCFY1.13%
OCF(TTM)1.94
OCFY1.43%
SpS68.83
BVpS10.08
TBVpS-5.95
PEG (NY)1.36
PEG (5Y)N/A
Graham Number15.21
Profitability
Industry RankSector Rank
ROA 2.14%
ROE 7.13%
ROCE 5.92%
ROIC 4.68%
ROICexc 4.83%
ROICexgc 14.34%
OM 2.15%
PM (TTM) 1.04%
GM 12.3%
FCFM 2.22%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
ROICexc(3y)3.47%
ROICexc(5y)3.63%
ROICexgc(3y)17.05%
ROICexgc(5y)18.21%
ROCE(3y)4.37%
ROCE(5y)4.5%
ROICexgc growth 3Y-9.4%
ROICexgc growth 5Y19.06%
ROICexc growth 3Y-3.14%
ROICexc growth 5Y18.48%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
F-Score7
Asset Turnover2.05
Health
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF 9.17
Debt/EBITDA 5.55
Cap/Depr 40.71%
Cap/Sales 0.59%
Interest Coverage 1.44
Cash Conversion 78.31%
Profit Quality 213.06%
Current Ratio 1.79
Quick Ratio 1.38
Altman-Z 5.88
F-Score7
WACC8.51%
ROIC/WACC0.55
Cap/Depr(3y)36.76%
Cap/Depr(5y)33.73%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%254.55%
EPS Next Y97.42%
EPS Next 2Y57.83%
EPS Next 3Y45.31%
EPS Next 5Y42.2%
Revenue 1Y (TTM)17.23%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%14.7%
Revenue Next Year13.42%
Revenue Next 2Y14.12%
Revenue Next 3Y13.85%
Revenue Next 5Y15.42%
EBIT growth 1Y36.15%
EBIT growth 3Y-4.13%
EBIT growth 5Y26.66%
EBIT Next Year63.58%
EBIT Next 3Y29.11%
EBIT Next 5Y26.38%
FCF growth 1Y324.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y820.28%
OCF growth 3Y-55.52%
OCF growth 5Y-26.51%

BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 / BTSGU FAQ

What is the fundamental rating for BTSGU stock?

ChartMill assigns a fundamental rating of 4 / 10 to BTSGU.


Can you provide the valuation status for BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27?

ChartMill assigns a valuation rating of 2 / 10 to BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU). This can be considered as Overvalued.


Can you provide the profitability details for BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27?

BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU) has a profitability rating of 4 / 10.


What are the PE and PB ratios of BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU) stock?

The Price/Earnings (PE) ratio for BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU) is 132.71 and the Price/Book (PB) ratio is 13.42.


Can you provide the financial health for BTSGU stock?

The financial health rating of BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU) is 4 / 10.